Labat Africa Ltd
Company Profile
Business description
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Bulk Logistics, and Healthcare. The Healthcare segment generates maximum revenue for the company and focuses on cannabis cultivation and extraction (High THC), CBD pharmaceutical and medicinal products as well as a range of agricultural Hemp products in both the food and drug areas as well as in the Industrial market, utilizing scientific, medical skills, technology and formulations. Geographically, the company carries out its business operations in South Africa.
Contact
23 Kroton Avenue
Weltevreden Park Roodepoort
JohannesburgGT1709
ZAFT: +27 116756841
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 May 2025
Employees
43
Stocks News & Analysis
stocks
Ask the analyst: Could Endeavour suffer from lower booze consumption and tighter gambling rules?
stocks
Should you avoid this highflying ASX share?
stocks
ASX gold play to take advantage of surging prices
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,250.00 | 76.40 | -0.92% |
| CAC 40 | 8,197.67 | 23.92 | 0.29% |
| DAX 40 | 23,419.48 | 338.45 | 1.47% |
| Dow JONES (US) | 42,579.08 | 427.51 | -0.99% |
| FTSE 100 | 8,682.84 | 73.00 | -0.83% |
| HKSE | 24,369.71 | 775.50 | 3.29% |
| NASDAQ | 18,069.26 | 483.48 | -2.61% |
| Nikkei 225 | 37,704.93 | 286.69 | 0.77% |
| NZX 50 Index | 12,379.33 | 49.51 | -0.40% |
| S&P 500 | 5,738.52 | 104.11 | -1.78% |
| S&P/ASX 200 | 8,017.80 | 76.90 | -0.95% |
| SSE Composite Index | 3,381.10 | 39.13 | 1.17% |